Journal article
Variation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic
- Abstract:
- BACKGROUND: This study assessed the international variation in surgical neuro-oncology practice and 30-day outcomes of patients who had surgery for an intracranial tumor during the COVID-19 pandemic./ METHODS: We prospectively included adults aged ≥18 years who underwent surgery for a malignant or benign intracranial tumor across 55 international hospitals from 26 countries. Each participating hospital recorded cases for 3 consecutive months from the start of the pandemic. We categorized patients’ location by World Bank income groups (high [HIC], upper-middle [UMIC], and low- and lower-middle [LLMIC]). Main outcomes were a change from routine management, SARS-CoV-2 infection, and 30-day mortality. We used a Bayesian multilevel logistic regression stratified by hospitals and adjusted for key confounders to estimate the association between income groups and mortality./ RESULTS: Among 1016 patients, the number of patients in each income group was 765 (75.3%) in HIC, 142 (14.0%) in UMIC, and 109 (10.7%) in LLMIC. The management of 200 (19.8%) patients changed from usual care, most commonly delayed surgery. Within 30 days after surgery, 14 (1.4%) patients had a COVID-19 diagnosis and 39 (3.8%) patients died. In the multivariable model, LLMIC was associated with increased mortality (odds ratio 2.83, 95% credible interval 1.37–5.74) compared to HIC./ CONCLUSIONS: The first wave of the pandemic had a significant impact on surgical decision-making. While the incidence of SARS-CoV-2 infection within 30 days after surgery was low, there was a disparity in mortality between countries and this warrants further examination to identify any modifiable factors
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 468.7KB, Terms of use)
-
- Publisher copy:
- 10.1093/neuonc/noad019
- Publication website:
- https://discovery.ucl.ac.uk/10168250/1/noad019.pdf
Authors
+ National Institute for Health Research
More from this funder
- Funder identifier:
- 10.13039/501100000272
- Grant:
- NIHR 16.136.79
+ Vascular Society for Great Britain and Ireland
More from this funder
- Funder identifier:
- 10.13039/501100023470
- Publisher:
- Oxford University Press
- Journal:
- Neuro-Oncology More from this journal
- Volume:
- 25
- Issue:
- 7
- Pages:
- 1299-1309
- Publication date:
- 2023-04-13
- DOI:
- EISSN:
-
1523-5866
- ISSN:
-
1522-8517
- Language:
-
English
- Keywords:
- Pubs id:
-
1350125
- Local pid:
-
pubs:1350125
- Source identifiers:
-
W4365442816
- Deposit date:
-
2026-05-08
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2023
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Oxford University Press at https://doi.org/10.1093/neuonc/noad019
If you are the owner of this record, you can report an update to it here: Report update to this record